Literature DB >> 31902893

Semi-continuous Production of 2-Ethyl Hexyl Ester in a Packed Bed Reactor: Optimization and Economic Evaluation.

Hadeel Hosney1,2, Ahmad Mustafa3,4.   

Abstract

The aim of this work was to investigate the technical as well as the economic feasibility of producing 2-ethyl hexyl oleate (2-EHO), a non-phthalate plasticizer in a solvent free medium. The esterification reaction between oleic acid and 2-ethyl hexyl alcohol was carried out in a packed bed reactor (PBR) using Candida antarctica lipase B (Novozym 435; Novozymes; Copenhagen-Denmark) as biocatalyst. RSM was employed to optimize the esterification reaction conditions. The optimum reaction conditions were found to be flow rate of 1.5 mL/min, No. of cycles of 12 and molar ratio of 4:1 2-ethyl hexanol to oleic acid. The maximum experimental and predicated conversions were found to be 95.8% and 95.61% respectively. Formation of 2-EHO was approved by FTIR, 1HNMR and 13CNMR. From the economic prospective, PBR was capable of producing 2-EHO with a purity of more than 94% over 480 h without remarkable reduction of enzyme activity. This revealed an economic production of 2-EHO at a yield of 2 tons kg-1 lipase. The manufacturing cost was found to be $ 1.88 /kg 2-EHO, this contributed to a profit of about 30% compared to the commercial price of 2-EHO. Such results approve the technical and economic feasibility for this sustainable method in esters production.

Entities:  

Keywords:  Novozym 435; esterification; manufacturing cost; oleic acid; packed bed reactor

Mesh:

Substances:

Year:  2020        PMID: 31902893     DOI: 10.5650/jos.ess19229

Source DB:  PubMed          Journal:  J Oleo Sci        ISSN: 1345-8957            Impact factor:   1.601


  1 in total

1.  Efficacy and durability of bovine virus diarrhea (BVD) virus killed vaccine adjuvanted with monolaurin.

Authors:  Maha Raafat Abd El Fadeel; Eman M Soliman; Ahmad Mohammad Allam; Mohamed F ElKersh; Rehab Mahmoud Abd El-Baky; Ahmad Mustafa
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.